Maddalena Guandalini

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Venues

Journal of neurology

Biomedicines

Bioengineering (Basel, Switzerland)

Brain sciences

University of Verona

University of Padua (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Verona Sep 01 2017

Italy

Research assistant :: Department of Neuroscience, Biomedicine and Movement Sciences

Education History

University of Padua

Italy

MSC :: Department of General Psychology

University of Padua

Italy

BSC :: Department of General Psychology

Publications

Massimiliano Calabrese, Agnese Tamanti, Angela Peloso, Stefano Ziccardi, Maddalena Guandalini, Milena Calderone, Marco Castellaro, Francesca Benedetta Pizzini, Stefania Montemezzi, Damiano Marastoni, Massimiliano Calabrese
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis. Journal of neurology (2024)
Massimiliano Calabrese, Agnese Tamanti, Angela Peloso, Stefano Ziccardi, Maddalena Guandalini, Milena Calderone, Marco Castellaro, Francesca Benedetta Pizzini, Stefania Montemezzi, Damiano Marastoni, Massimiliano Calabrese
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis. Journal of neurology 271 (5) (2024)
Massimiliano Calabrese, Agnese Tamanti, Angela Peloso, Stefano Ziccardi, Maddalena Guandalini, Milena Calderone, Marco Castellaro, Francesca Benedetta Pizzini, Stefania Montemezzi, Damiano Marastoni, Massimiliano Calabrese
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis. Journal of neurology 271 (5) (2024)
Massimiliano Calabrese, Agnese Tamanti, Angela Peloso, Stefano Ziccardi, Maddalena Guandalini, Milena Calderone, Marco Castellaro, Francesca Benedetta Pizzini, Stefania Montemezzi, Damiano Marastoni, Massimiliano Calabrese
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis. Journal of neurology 271 (5) (2024)
Massimiliano Calabrese, Agnese Tamanti, Angela Peloso, Stefano Ziccardi, Maddalena Guandalini, Milena Calderone, Marco Castellaro, Francesca Benedetta Pizzini, Stefania Montemezzi, Damiano Marastoni, Massimiliano Calabrese
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis. Journal of neurology 271 (5) (2024)
Massimiliano Calabrese, Agnese Tamanti, Angela Peloso, Stefano Ziccardi, Maddalena Guandalini, Milena Calderone, Marco Castellaro, Francesca Benedetta Pizzini, Stefania Montemezzi, Damiano Marastoni, Massimiliano Calabrese
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis. Journal of neurology 271 (5) (2024)
Stefano Ziccardi, Anna Isabella Pisani, Gian Marco Schiavi, Maddalena Guandalini, Francesco Crescenzo, Annalisa Colombi, Angela Peloso, Agnese Tamanti, Maddalena Bertolazzo, Damiano Marastoni, Massimiliano Calabrese
Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: A 20-year study. European journal of neurology (2023)
Valentina Mazziotti, Francesco Crescenzo, Agnese Tamanti, Caterina Dapor, Stefano Ziccardi, Maddalena Guandalini, Annalisa Colombi, Valentina Camera, Angela Peloso, Francesco Pezzini, Ermanna Turano, Damiano Marastoni, Massimiliano Calabrese
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs. Biomedicines 10 (12) (2022)
Stefano Ziccardi, Francesca Benedetta Pizzini, Maddalena Guandalini, Agnese Tamanti, Cecilia Cristofori, Massimiliano Calabrese
Making Visible the Invisible: Automatically Measured Global and Regional Brain Volume Is Associated with Cognitive Impairment and Fatigue in Multiple Sclerosis. Bioengineering (Basel, Switzerland) 10 (1) (2022)
Valentina Mazziotti, Francesco Crescenzo, Agnese Tamanti, Caterina Dapor, Stefano Ziccardi, Maddalena Guandalini, Annalisa Colombi, Valentina Camera, Angela Peloso, Francesco Pezzini, Ermanna Turano, Damiano Marastoni, Massimiliano Calabrese
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs. Biomedicines 10 (12) (2022)
Stefano Ziccardi, Francesca Benedetta Pizzini, Maddalena Guandalini, Agnese Tamanti, Cecilia Cristofori, Massimiliano Calabrese
Making Visible the Invisible: Automatically Measured Global and Regional Brain Volume Is Associated with Cognitive Impairment and Fatigue in Multiple Sclerosis. Bioengineering (Basel, Switzerland) 10 (1) (2022)
Silvia Cerea, Marta Ghisi, Marco Pitteri, Maddalena Guandalini, Lauren B Strober, Simona Scozzari, Francesco Crescenzo, Massimiliano Calabrese
Coping Strategies and Their Impact on Quality of Life and Physical Disability of People with Multiple Sclerosis. Journal of clinical medicine 10 (23) (2021)
Marco Pitteri, Caterina Dapor, Stefano Ziccardi, Maddalena Guandalini, Riccardo Meggiato, Massimiliano Calabrese
Visual-Attentional Load Unveils Slowed Processing Speed in Multiple Sclerosis Patients: A Pilot Study with a Tablet-Based Videogame. Brain sciences 10 (11) (2020)
Marco Pitteri, Caterina Dapor, Anna Isabella Pisani, Marco Castellaro, John DeLuca, Nancy D Chiaravalloti, Maddalena Guandalini, Stefano Ziccardi, Massimiliano Calabrese
Executive functioning affects verbal learning process in multiple sclerosis patients: Behavioural and imaging results. Journal of neuropsychology 14 (3) (2019)

Maddalena Guandalini.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Maddalena Guandalini